VB

Veluswamy Bindhya

Active Director Additional Director DIN 11044751
DIN 11044751 First appointment Apr 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Veluswamy Bindhya

Data last updated:

Veluswamy Bindhya is an Additional Director at Asepsis Healthcare India Private Limited (since 2025). The company operates in Paper.

DIN 11044751
Primary Designation Additional Director
Industry Paper
First Appointment 09 Apr 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director09 Apr 20252024Active

Board colleagues of Veluswamy Bindhya

Directorship timeline

Open interactive timeline →
Asepsis Healthcare India Private Limited
Premium access

Shareholding and investment profile for Veluswamy Bindhya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Veluswamy Bindhya

Veluswamy Bindhya currently holds 1 directorship: Asepsis Healthcare India Private Limited (Additional Director, since 09 Apr 2025).

Veluswamy Bindhya was first appointed on 09 Apr 2025 as Additional Director at Asepsis Healthcare India Private Limited.

The current boards of Veluswamy Bindhya's companies include Karthikeyan (Asepsis Healthcare India Private Limited), Moideen Akbar Veshkar (Asepsis Healthcare India Private Limited), Prabhaharan Lakshmanan (Asepsis Healthcare India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available